Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Vitamin D helps protect skin, PSORS1 gene's risk interval for psoriasis is expanded, hair follicles can be generated from mouse cells, and interferon-γ may cause pigmented skin lesions.

A genetic mutation in the LIPH gene causes hair loss and growth defects.

Various treatments can improve post-acne scars, but results vary.

Sulfasalazine may help regrow hair in severe alopecia areata cases.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Genes affect cytokine production, which can influence chronic diseases, and certain interventions may help prevent related molecular damage.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Amniotic allograft may be more effective than platelet-rich plasma for midface aging treatment.

Combined prednisone and cyclosporine therapy led to excellent hair regrowth and improved well-being.

Phototherapy can help treat hair loss in alopecia areata.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Honokiol from Magnolia plants may be beneficial for treating various skin conditions and promoting hair growth.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Shock can be an early sign of Autoimmune Polyendocrine Syndrome Type II.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Combining stem cell-conditioned media with anti-androgen drugs can improve hair growth in male pattern baldness.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Person-to-person hair transplants can work for patients on lifelong immunosuppression, with high hair growth success.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Alopecia totalis/universalis is a severe form of hair loss where all body hair is lost.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.